pI: 10.6886 |
Length (AA): 305 |
MW (Da): 33985 |
Paralog Number:
2
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 4 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
11 | 259 | 1vq8 (N) | 1 | 182 | 34.00 | 0 | 1 | 0.66 | 1 |
48 | 148 | 1ily (A) | 22 | 111 | 29.00 | 0 | 0.66 | 0.47 | -0.28 |
11 | 260 | 1vq8 (N) | 1 | 183 | 34.00 | 0 | 1 | 0.748972 | 1.15 |
187 | 301 | 5cwk (A) | 43 | 169 | 29.00 | 0.14 | 0.69 | 0.600949 | 0.06 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | amastigotes, metacyclic. | Fernandes MC |
Fernandes MC | Dual Transcriptome Profiling of Leishmania-Infected Human Macrophages Reveals Distinct Reprogramming Signatures. |
Ortholog group members (OG5_127090)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT3G25520 | 60S ribosomal protein L5-1 |
Arabidopsis thaliana | AT5G39740 | 60S ribosomal protein L5-2 |
Babesia bovis | BBOV_III010590 | ribosomal L18p/L5e family protein |
Brugia malayi | Bm1_32050 | 60S ribosomal protein L5 |
Candida albicans | CaO19.6541 | likely cytosolic ribosomal protein similar to S. cerevisiae RPL5 (YPL131W) large subunit protein L5 |
Candida albicans | CaO19.13894 | likely cytosolic ribosomal protein similar to S. cerevisiae RPL5 (YPL131W) large subunit protein L5 |
Candida albicans | CaO19_6541 | hypothetical protein |
Caenorhabditis elegans | CELE_F54C9.5 | Protein RPL-5 |
Cryptosporidium hominis | Chro.80056 | ribosomal protein L5A |
Cryptosporidium parvum | cgd8_440 | 60S ribosomal protein L5 |
Dictyostelium discoideum | DDB_G0278539 | 60S ribosomal protein L5 |
Drosophila melanogaster | Dmel_CG17489 | Ribosomal protein L5 |
Echinococcus granulosus | EgrG_001099800 | dnaj subfamily c |
Echinococcus granulosus | EgrG_000217700 | ribosomal protein l5 |
Entamoeba histolytica | EHI_006860 | 60S ribosomal protein L5, putative |
Entamoeba histolytica | EHI_068660 | 60S ribosomal protein L5, putative |
Echinococcus multilocularis | EmuJ_001099800 | dnaj subfamily c |
Echinococcus multilocularis | EmuJ_000217700 | ribosomal protein l5 |
Giardia lamblia | GL50803_17395 | Ribosomal protein L5 |
Homo sapiens | ENSG00000122406 | ribosomal protein L5 |
Leishmania braziliensis | LbrM.34.1790 | 60S ribosomal protein L5, putative |
Leishmania braziliensis | LbrM.34.1800 | 60S ribosomal protein L5, putative |
Leishmania donovani | LdBPK_351870.1 | 60S ribosomal protein L5, putative |
Leishmania infantum | LinJ.35.1870 | 60S ribosomal protein L5, putative |
Leishmania infantum | LinJ.35.1880 | 60S ribosomal protein L5, putative |
Leishmania major | LmjF.35.1900 | 60S ribosomal protein L5, putative |
Leishmania major | LmjF.35.1880 | 60S ribosomal protein L5, putative |
Leishmania major | LmjF.35.1890 | 60S ribosomal protein L5, putative |
Leishmania mexicana | LmxM.34.1900 | 60S ribosomal protein L5, putative |
Leishmania mexicana | LmxM.34.1890 | 60S ribosomal protein L5, putative |
Leishmania mexicana | LmxM.34.1880 | 60S ribosomal protein L5, putative |
Loa Loa (eye worm) | LOAG_10343 | 60S ribosomal protein L5 |
Mus musculus | ENSMUSG00000058558 | ribosomal protein L5 |
Neospora caninum | NCLIV_010200 | hypothetical protein |
Oryza sativa | 4325100 | Os01g0896800 |
Oryza sativa | 9271934 | Os01g0896620 |
Onchocerca volvulus | OVOC3377 | 60S ribosomal protein L5 homolog |
Plasmodium berghei | PBANKA_1019500 | 60S ribosomal protein L5, putative |
Plasmodium falciparum | PF3D7_1424100 | 60S ribosomal protein L5, putative |
Plasmodium knowlesi | PKNH_1333800 | 60S ribosomal protein L5, putative |
Plasmodium vivax | PVX_085275 | 60S ribosomal protein L5, putative |
Plasmodium yoelii | PY06459 | Ribosomal L18p/L5e family, putative |
Saccharomyces cerevisiae | YPL131W | ribosomal 60S subunit protein L5 |
Schistosoma japonicum | Sjp_0302150 | ko:K09521 DnaJ homolog, subfamily C, member 1, putative |
Schistosoma japonicum | Sjp_0037600 | ko:K02932 large subunit ribosomal protein L5e, putative |
Schistosoma japonicum | Sjp_0037580 | ko:K09521 DnaJ homolog, subfamily C, member 1, putative |
Schistosoma mansoni | Smp_173390 | ribosomal protein L5 |
Schmidtea mediterranea | mk4.002247.02 | 60S ribosomal protein L5 |
Schmidtea mediterranea | mk4.005212.03 | 60S ribosomal protein L5 |
Schmidtea mediterranea | mk4.005763.02 | 60S ribosomal protein L5 |
Trypanosoma brucei gambiense | Tbg972.9.9370 | 60S ribosomal protein L5, putative |
Trypanosoma brucei gambiense | Tbg972.9.9390 | 60S ribosomal protein L5, putative |
Trypanosoma brucei | Tb927.9.15170 | 60S ribosomal protein L5, putative |
Trypanosoma brucei | Tb927.9.15110 | 60S ribosomal protein L5, putative |
Trypanosoma congolense | TcIL3000_9_6340 | 60S ribosomal protein L5, putative |
Trypanosoma cruzi | TcCLB.509671.80 | 60S ribosomal protein L5, putative |
Trypanosoma cruzi | TcCLB.510765.70 | 60S ribosomal protein L5, putative |
Trypanosoma cruzi | TcCLB.510765.60 | 60S ribosomal protein L5, putative |
Toxoplasma gondii | TGME49_320050 | ribosomal protein RPL5 |
Theileria parva | TP02_0082 | 60S ribosomal protein L5e, putative |
Trichomonas vaginalis | TVAG_064640 | ribosomal protein L5, putative |
Trichomonas vaginalis | TVAG_454000 | ribosomal protein L5, putative |
Trichomonas vaginalis | TVAG_113720 | ribosomal protein L5, putative |
Trichomonas vaginalis | TVAG_490240 | ribosomal protein L5, putative |
Trichomonas vaginalis | TVAG_466650 | ribosomal protein L5, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb09.244.2730 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (3 days) | alsford |
Tb09.244.2730 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb09.244.2730 | Trypanosoma brucei | significant loss of fitness in procyclic forms | alsford |
Tb09.244.2730 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_F54C9.5 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_F54C9.5 | Caenorhabditis elegans | larval arrest | wormbase |
CELE_F54C9.5 | Caenorhabditis elegans | slow growth | wormbase |
CELE_F54C9.5 | Caenorhabditis elegans | sterile | wormbase |
YPL131W | Saccharomyces cerevisiae | inviable | yeastgenome |
TGME49_320050 | Toxoplasma gondii | Probably essential | sidik |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.